Skip to content

FibroBiologics, Inc.

FBLG

CIK 0001958777

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$20.4M
−67.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.29
−23.5% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$16.06M
Q1 May 2026
Cash
$1.48M
Q1 May 2026
Total Debt
$60K
Q1 May 2026
Shares Outstanding
5.21M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings